About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [733 citations: 101–200 of 694 articles]

Articles published in Prostate Cancer have been cited 733 times. The following is a list of the 694 articles that have cited the articles published in Prostate Cancer.

  • Francois Rozet, Thierry Roumeguère, Martin Spahn, Dirk Beyersdorff, and Peter Hammerer, “Non-metastatic castrate-resistant prostate cancer: a call for improved guidance on clinical management,” World Journal of Urology, 2016. View at Publisher · View at Google Scholar
  • Hyun-Ju Seo, Na Rae Lee, Soo Kyung Son, Dae Keun Kim, Koon Ho Rha, and Seon Heui Lee, “Comparison of Robot-Assisted Radical Prostatectomy and Open Radical Prostatectomy Outcomes: A Systematic Review and Meta-Analysis,” Yonsei Medical Journal, vol. 57, no. 5, pp. 1165, 2016. View at Publisher · View at Google Scholar
  • Andrew B. Rosenkrantz, and Samir S. Taneja, “Magnetic Resonance Sentinel Lymph Node Detection in Prostate Cancer,” Academic Radiology, 2015. View at Publisher · View at Google Scholar
  • Laura Van den Bergh, Steven Joniau, Karin Haustermans, Christophe M. Deroose, Sofie Isebaert, Raymond Oyen, Felix M. Mottaghy, Filip Ameye, Joost Berkers, Hendrik Van Poppel, and Evelyne Lerut, “Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement,” Acta Oncologica, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • A. Guijarro, L. Reguero, V. Hernández, J.M. de la Morena, E. De la Peña, B. López, B. Fernández, C. Parrilla, E. Pérez-Fernández, I. Alemany, and C. Llorente, “Rentabilidad diagnóstica y complicaciones de la linfadenectomía ampliada frente a la limitada asociada a prostatectomía radical,” Actas Urológicas Españolas, 2015. View at Publisher · View at Google Scholar
  • Fouad Aoun, Ksenija Limani, Alexandre Peltier, Quentin Marcelis, Marc Zanaty, Alexandre Chamoun, Marc Vanden Bossche, Thierry Roumeguère, and Roland van Velthoven, “High Intensity Focused Ultrasound versus Brachytherapy for the Treatment of Localized Prostate Cancer: A Matched-Pair Analysis,” Advances in Urology, vol. 2015, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • None Sawada, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Shizuka Sasazuki, Manami Inoue, and Shoichiro Tsugane, “Fiber intake and risk of subsequent prostate cancer in Japanese men,” American Journal Of Clinical Nutrition, vol. 101, no. 1, pp. 118–125, 2015. View at Publisher · View at Google Scholar
  • Ian R. Hambleton, Selvi Jeyaseelan, Christina Howitt, Natasha Sobers-Grannum, Anselm J. Hennis, Rainford J. Wilks, E. Nigel Harris, Marlene MacLeish, and Louis W. Sullivan, “Cause-of-Death Disparities in the African Diaspora: Exploring Differences Among Shared-Heritage Populations,” American Journal of Public Health, vol. 105, no. S3, pp. S491–S498, 2015. View at Publisher · View at Google Scholar
  • Wajahat Khalil, Hong Xia, Vidya Bodempudi, Judy Kahm, Polla Hergert, Karen Smith, Mark Peterson, Matthew Parker, Jeremy Herrera, Peter B. Bitterman, and Craig A. Henke, “Pathologic Regulation of Collagen I by an Aberrant Protein Phosphatase 2A/Histone Deacetylase C4/MicroRNA-29 Signal Axis in Idiopathic Pulmonary Fibrosis Fibroblasts,” American Journal of Respiratory Cell and Molecular Biology, vol. 53, no. 3, pp. 391–399, 2015. View at Publisher · View at Google Scholar
  • Alex Stepan, Cristiana Simionescu, Daniel Pirici, Raluca Ciurea, and Claudiu Margaritescu, “Fractal Analysis and the Diagnostic Usefulness of Silver Staining Nucleolar Organizer Regions in Prostate Adenocarcinoma,” Analytical Cellular Pathology, vol. 2015, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • R. Yang, F. Fang, J. Wang, and H. Guo, “Adipose-derived stem cells ameliorate erectile dysfunction after cavernous nerve cryoinjury,” Andrology, vol. 3, no. 4, pp. 694–701, 2015. View at Publisher · View at Google Scholar
  • Guenther Wolfram, Angela Bechthold, Heiner Boeing, Sabine Ellinger, Hans Hauner, Anja Kroke, Eva Leschik-Bonnet, Jakob Linseisen, Stefan Lorkowski, Matthias Schulze, Peter Stehle, and Jessica Dinter, “Evidence-Based Guideline of the German Nutrition Society: Fat Intake and Prevention of Selected Nutrition-Related Diseases,” Annals Of Nutrition And Metabolism, vol. 67, no. 3, pp. 141–204, 2015. View at Publisher · View at Google Scholar
  • Eben L. Rosenthal, Jason M. Warram, Kirby I. Bland, and Kurt R. Zinn, “The Status of Contemporary Image-Guided Modalities in Oncologic Surgery,” Annals of Surgery, vol. 261, no. 1, pp. 46–55, 2015. View at Publisher · View at Google Scholar
  • Yi Yang Liu, Po Hui Chiang, Yao Chi Chuang, Wei Ching Lee, Yuan Tso Cheng, and Hung Jen Wang, “Predictors of Prostate-Specific Antigen Biochemical Recurrence in Patients Undergoing Primary Whole-Gland Prostate Cryoablation,” Annals Of Surgical Oncology, vol. 22, no. 5, pp. 1612–1617, 2015. View at Publisher · View at Google Scholar
  • Yi Yang Liu, and Po Hui Chiang, “Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer,” Annals of Surgical Oncology, 2015. View at Publisher · View at Google Scholar
  • Avinash Kumar, Swati Dhar, Agnes M. Rimando, Janice M. Lage, Jack R. Lewin, Xu Zhang, and Anait S. Levenson, “Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer,” Annals of the New York Academy of Sciences, 2015. View at Publisher · View at Google Scholar
  • Suman Bhattacharya, Mohammad Hirmand, De Phung, and Steve van Os, “Development of enzalutamide for metastatic castration-resistant prostate cancer,” Annals of the New York Academy of Sciences, 2015. View at Publisher · View at Google Scholar
  • Yao Zhu, Hong-Kai Wang, Yuan-Yuan Qu, and Ding-Wei Ye, “Prostate cancer in East Asia: evolving trend over the last decade,” Asian Journal Of Andrology, vol. 17, no. 1, pp. 48–57, 2015. View at Publisher · View at Google Scholar
  • Parth Malik, Narender Chaudhry, Rashmi Mittal, and Tapan K. Mukherjee, “Role of receptor for advanced glycation end products in the complication and progression of various types of cancers,” Biochimica Et Biophysica Acta-General Subjects, vol. 1850, no. 9, pp. 1898–1904, 2015. View at Publisher · View at Google Scholar
  • Victoria Hillerdal, and Magnus Essand, “Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer,” BioDrugs, 2015. View at Publisher · View at Google Scholar
  • Karsten H. Weylandt, Simona Serini, Yong Q. Chen, Hui-Min Su, Kyu Lim, Achille Cittadini, and Gabriella Calviello, “Omega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed Evidence,” BioMed Research International, vol. 2015, pp. 1–24, 2015. View at Publisher · View at Google Scholar
  • Hua Xu, Meng-bo Hu, Pei-de Bai, Wen-hui Zhu, Sheng-hua Liu, Jun-yao Hou, Zu-quan Xiong, Qiang Ding, and Hao-wen Jiang, “Proinflammatory Cytokines in Prostate Cancer Development and Progression Promoted by High-Fat Diet,” BioMed Research International, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Yi-Chien Lu, Wen-Chin Weng, and Hsinyu Lee, “Functional Roles of Calreticulin in Cancer Biology,” BioMed Research International, vol. 2015, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Alexandre Peltier, Fouad Aoun, Marc Lemort, Félix Kwizera, Marianne Paesmans, and Roland Van Velthoven, “MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men,” BioMed Research International, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Jacob J. Elmer, Matthew D. Christensen, Sutapa Barua, Jennifer Lehrman, Karmella A. Haynes, and Kaushal Rege, “The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines,” Biotechnology and Bioengineering, vol. 113, no. 6, pp. 1345–1356, 2015. View at Publisher · View at Google Scholar
  • Alan L. Patrick, Clareann H. Bunker, Joel B. Nelson, Rajiv Dhir, Victor W. Wheeler, Joseph M. Zmuda, Jean-Robert Richard, Andrew C. Belle, and Lewis H. Kuller, “Argument for prostate cancer screening in populations of African-Caribbean origin,” BJU International, 2015. View at Publisher · View at Google Scholar
  • Philipp Mandel, Thomas Steuber, Sascha Ahyai, Maximilian Kriegmair, Jonas Schiffmann, Katharina Boehm, Hans Heinzer, Uwe Michl, Thorsten Schlomm, Alexander Haese, Hartwig Huland, Markus Graefen, and Derya Tilki, “Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria,” BJU International, 2015. View at Publisher · View at Google Scholar
  • Thomas WH Lui, Nancy BY Tsui, Lawrence WC Chan, Cesar SC Wong, Parco MF Siu, and Benjamin YM Yung, “DECODE: an integrated differential co-expression and differential expression analysis of gene expression data,” BMC Bioinformatics, vol. 16, no. 1, 2015. View at Publisher · View at Google Scholar
  • Xiaohui Xu, Xinguang Chen, Hui Hu, Amy B. Dailey, and Brandie D. Taylor, “Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model,” Bmc Cancer, vol. 15, 2015. View at Publisher · View at Google Scholar
  • Gregor Habl, Sonja Katayama, Matthias Uhl, Kerstin A. Kessel, Lutz Edler, Juergen Debus, Klaus Herfarth, and Florian Sterzing, “Helical intensity-modulated radiotherapy of the pelvic lymph nodes with a simultaneous integrated boost to the prostate - first results of the PLATIN 1 trial,” BMC Cancer, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  • Pao-Hwa Lin, William Aronson, and Stephen J. Freedland, “Nutrition, dietary interventions and prostate cancer: the latest evidence,” Bmc Medicine, vol. 13, 2015. View at Publisher · View at Google Scholar
  • Ilir Agalliu, Akin O Adebiyi, David W Lounsbury, Oluwafemi Popoola, Kola Jinadu, Olukemi Amodu, Suvam Paul, Adebola Adedimeji, Chioma Asuzu, Michael Asuzu, Olufemi J Ogunbiyi, Thomas Rohan, and Olayiwola B Shittu, “The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria,” BMC Public Health, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  • Shalini Singh, Chunliu Pan, Ronald Wood, Chiuan-Ren Yeh, Shuyuan Yeh, Kai Sha, John J. Krolewski, and Kent L. Nastiuk, “Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound,” BMC Urology, vol. 15, no. 1, 2015. View at Publisher · View at Google Scholar
  • Koen Raymaekers, Steve Stegen, Nick van Gastel, and Geert Carmeliet, “The vasculature: a vessel for bone metastasis,” BoneKEy Reports, pp. 742, 2015. View at Publisher · View at Google Scholar
  • Marc Bienz, and Fred Saad, “Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review,” BoneKEy Reports, vol. 4, pp. 716, 2015. View at Publisher · View at Google Scholar
  • Robyn Banerjee, Sang-June Park, Erik Anderson, D. Jeffrey Demanes, Jason Wang, and Mitchell Kamrava, “From whole gland to hemigland to ultra-focal high-dose rate prostate brachytherapy: A dosimetric analysis,” Brachytherapy, 2015. View at Publisher · View at Google Scholar
  • Ann C. Raldow, Danjie Zhang, Ming-Hui Chen, Michelle H. Braccioforte, Brian J. Moran, and Anthony V. D'Amico, “Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy,” Brachytherapy, 2015. View at Publisher · View at Google Scholar
  • Jiao Li, Si Zheng, Bin Chen, Atul J. Butte, S. Joshua Swamidass, and Zhiyong Lu, “A survey of current trends in computational drug repositioning,” Briefings in Bioinformatics, vol. 17, no. 1, pp. 2–12, 2015. View at Publisher · View at Google Scholar
  • Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, and Ahmedin Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, 2015. View at Publisher · View at Google Scholar
  • Hannah K. Weir, Trevor D. Thompson, Ashwini Soman, Bjørn Møller, and Steven Leadbetter, “The past, present, and future of cancer incidence in the United States: 1975 through 2020,” Cancer, 2015. View at Publisher · View at Google Scholar
  • Chad A. Reichard, Andrew J. Stephenson, and Eric A. Klein, “Applying precision medicine to the active surveillance of prostate cancer,” Cancer, 2015. View at Publisher · View at Google Scholar
  • Matteo Santoni, Francesco Piva, Marina Scarpelli, Liang Cheng, Antonio Lopez-Beltran, Francesco Massari, Roberto Iacovelli, Rossana Berardi, Daniele Santini, and Rodolfo Montironi, “The origin of prostate metastases: emerging insights,” Cancer and Metastasis Reviews, 2015. View at Publisher · View at Google Scholar
  • Jeannette M. Schenk, Cathee Till, Ann W. Hsing, Frank Z. Stanczyk, Zhihong Gong, Marian L. Neuhouser, Juergen K. Reichardt, Ashraful M. Hoque, William D. Figg, Phyllis J. Goodman, Catherine M. Tangen, and Ian M. Thompson, “Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial,” Cancer Causes & Control, 2015. View at Publisher · View at Google Scholar
  • Pierrick G.J. Fournier, Patricia Juárez, Guanglong Jiang, Gregory A. Clines, Maria Niewolna, Hun Soo Kim, Holly W. Walton, Xiang Hong Peng, Yunlong Liu, Khalid S. Mohammad, Clark D. Wells, John M. Chirgwin, and Theresa A. Guise, “The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone,” Cancer Cell, 2015. View at Publisher · View at Google Scholar
  • Michael Cheng, Li Zhang, Margaret Borok, Eric Chokunonga, Charles Dzamamala, Anne Korir, Henry R. Wabinga, Robert A. Hiatt, D. Max Parkin, and Katherine Van Loon, “The incidence of oesophageal cancer in Eastern Africa: Identification of a new geographic hot spot?,” Cancer Epidemiology, 2015. View at Publisher · View at Google Scholar
  • Justin B. Emtage, Michael A. Poch, Maisha T. Hutton, and Jerry B. Emtage, “Prostate cancer trends in Barbados: An analysis of the Barbados Urologic Diseases Survey database,” Cancer Epidemiology, vol. 39, no. 6, pp. 825–830, 2015. View at Publisher · View at Google Scholar
  • Kendra Schwartz, Julie J. Ruterbusch, Joanne S. Colt, David C. Miller, Wong-Ho Chow, and Mark P. Purdue, “Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors,” Cancer Medicine, 2015. View at Publisher · View at Google Scholar
  • Monica Cojoc, Claudia Peitzsch, Ina Kurth, Franziska Trautmann, Leoni A. Kunz-Schughart, Gennady D. Telegeev, Eduard A. Stakhovsky, John R. Walker, Karl Simin, Stephen Lyle, Susanne Fuesse, Kati Erdmann, Manfred P. Wirth, Mechthild Krause, Michael Baumann, and Anna Dubrovska, “Aldehyde Dehydrogenase Is Regulated by beta-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells,” Cancer Research, vol. 75, no. 7, pp. 1482–1494, 2015. View at Publisher · View at Google Scholar
  • Shanliang Zhong, Xiaohui Zhang, Lin Chen, Tengfei Ma, Jinhai Tang, and Jianhua Zhao, “Statin use and mortality in cancer patients: Systematic review and meta-analysis of observational studies,” Cancer Treatment Reviews, 2015. View at Publisher · View at Google Scholar
  • Tangwei Wu, Weiqun Chen, Deyong Kong, Xiaoyi Li, Hongda Lu, Shuiyi Liu, Jing Wang, Lili Du, Qingzhi Kong, Xiaodong Huang, and Zhongxin Lu, “miR-25 targets the modulator of apoptosis 1 gene in lung cancer,” Carcinogenesis, vol. 36, no. 8, pp. 925–935, 2015. View at Publisher · View at Google Scholar
  • Corina E. Antal, Andrew M. Hudson, Emily Kang, Ciro Zanca, Christopher Wirth, Natalie L. Stephenson, Eleanor W. Trotter, Lisa L. Gallegos, Crispin J. Miller, Frank B. Furnari, Tony Hunter, John Brognard, and Alexandra C. Newton, “Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor,” Cell, 2015. View at Publisher · View at Google Scholar
  • Alexander V. Timoshenko, “Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions,” Cellular and Molecular Life Sciences, 2015. View at Publisher · View at Google Scholar
  • Huai-Hsuan Chiu, Sung-Jeng Tsai, Y. Jane Tseng, Ming-Shiang Wu, Wei-Chih Liao, Chiun-Sheng Huang, and Ching-Hua Kuo, “An efficient and robust fatty acid profiling method for plasma metabolomic studies by gas chromatography–mass spectrometry,” Clinica Chimica Acta, 2015. View at Publisher · View at Google Scholar
  • Ziauddin Zia Saad, and John R. Buscombe, “Sentinel lymph node: established and new areas of use,” Clinical and Translational Imaging, 2015. View at Publisher · View at Google Scholar
  • Bi-Dar Wang, Kristin Ceniccola, Qi Yang, Ramez Andrawis, Vyomesh Patel, Youngmi Ji, Johng Rhim, Jacqueline Olender, Anastas Popratiloff, Patricia Latham, Yinglei Lai, Steven R. Patierno, and Norman H. Lee, “Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities,” Clinical Cancer Research, vol. 21, no. 21, pp. 4970–4984, 2015. View at Publisher · View at Google Scholar
  • Pier-Luc Clermont, Dong Lin, Francesco Crea, Rebecca Wu, Hui Xue, Yuwei Wang, Kelsie L Thu, Wan L Lam, Colin C Collins, Yuzhuo Wang, and Cheryl D Helgason, “Polycomb-mediated silencing in neuroendocrine prostate cancer,” Clinical Epigenetics, vol. 7, no. 1, 2015. View at Publisher · View at Google Scholar
  • Bistra Galunska, Daniela Gerova, Petar Kosev, Deyan Anakievski, and Alexander Hinev, “Serum 25-Hydroxy Vitamin D Levels in Bulgarian Patients with Prostate Cancer: a Pilot Study,” Clinical Laboratory, vol. 61, no. 3-4, pp. 329–335, 2015. View at Publisher · View at Google Scholar
  • Rhonda Arthur, Alejo Rodríguez-Vida, Giorgia Zadra, Henrik Møller, and Mieke Van Hemelrijck, “Serum lipids as markers of prostate cancer occurrence and prognosis?,” Clinical Lipidology, vol. 10, no. 2, pp. 145–165, 2015. View at Publisher · View at Google Scholar
  • N. Somaiah, K. Rothkamm, and J. Yarnold, “Where Do We Look for Markers of Radiotherapy Fraction Size Sensitivity?,” Clinical Oncology, 2015. View at Publisher · View at Google Scholar
  • Jonathan C. Dunne, David S. Lamb, Brett Delahunt, Judith Murray, Peter Bethwaite, Peter Ferguson, John N. Nacey, Sven Sondhauss, and T. William Jordan, “Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease,” Clinical Proteomics, vol. 12, no. 1, 2015. View at Publisher · View at Google Scholar
  • Jgc van Hasselt, A Gupta, Z Hussein, Jh Beijnen, Jhm Schellens, and Adr Huitema, “Disease Progression/Clinical Outcome Model for Castration-Resistant Prostate Cancer in Patients Treated With Eribulin,” CPT: Pharmacometrics & Systems Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Kirk M. Anderson, Maxx Gallegos, Ty T. Higuchi, and Brian J. Flynn, “Evaluation and Management of Rectourethral Fistulas After Prostate Cancer Treatment,” Current Bladder Dysfunction Reports, 2015. View at Publisher · View at Google Scholar
  • Divaya Bhutani, and Lawrence G. Lum, “Activated T cells armed with bispecific antibodies kill tumor targets,” Current Opinion in Hematology, vol. 22, no. 6, pp. 476–483, 2015. View at Publisher · View at Google Scholar
  • Marc Bienz, and Fred Saad, “Management of bone metastases in prostate cancer,” Current Opinion in Supportive and Palliative Care, vol. 9, no. 3, pp. 261–267, 2015. View at Publisher · View at Google Scholar
  • Jonathan A. Coleman, “Functional outcomes of partial prostate ablation and focal therapy,” Current Opinion in Urology, vol. 25, no. 3, pp. 220–224, 2015. View at Publisher · View at Google Scholar
  • V. Kasivisvanathan, T.T. Shah, I. Donaldson, A. Kanthabalan, C.M. Moore, M. Emberton, and H.U. Ahmed, “Fokale Therapie des Prostatakarzinoms,” Der Urologe, vol. 54, no. 2, pp. 202–209, 2015. View at Publisher · View at Google Scholar
  • Jieke Yan, Yuzhen Wang, Xufeng Zhang, Shuangde Liu, Chuan Tian, and Hongwei Wang, “ Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo ,” Drug Delivery, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • C. Reviriego, “ARN-509 Androgen receptor signaling inhibitor Prostate cancer therapy,” Drugs Of The Future, vol. 40, no. 2, pp. 101–108, 2015. View at Publisher · View at Google Scholar
  • Federica Finetti, Erika Terzuoli, Antonio Giachetti, Raffaella Santi, Donata Villari, Hiromi Hanaka, Olof Radmark, Marina Ziche, and Sandra Donnini, “mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity,” Endocrine-Related Cancer, vol. 22, no. 4, pp. 665–678, 2015. View at Publisher · View at Google Scholar
  • Emma H Allott, and Stephen D Hursting, “Obesity and cancer: mechanistic insights from transdisciplinary studies,” Endocrine-Related Cancer, vol. 22, no. 6, pp. R365–R386, 2015. View at Publisher · View at Google Scholar
  • J. M. Devaney, S. Wang, P. Furbert-Harris, V. Apprey, M. Ittmann, B-D Wang, J. Olender, N. H. Lee, and B. Kwabi-Addo, “Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men,” Epigenetics, vol. 10, no. 4, pp. 319–328, 2015. View at Publisher · View at Google Scholar
  • Kazuhiro Ohwaki, Fumiyasu Endo, and Kazunori Hattori, “Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy,” European Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • Mohamed Jalloh, Frank Myers, Janet E. Cowan, Peter R. Carroll, and Matthew R. Cooperberg, “Racial Variation in Prostate Cancer Upgrading and Upstaging Among Men with Low-risk Clinical Characteristics,” European Urology, vol. 67, no. 3, pp. 451–457, 2015. View at Publisher · View at Google Scholar
  • Fred Saad, Neal Shore, Hendrik Van Poppel, Dana E. Rathkopf, Matthew R. Smith, Johann S. de Bono, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Peter F.A. Mulders, Paul Mainwaring, John D. Hainsworth, Tomasz M. Beer, Scott North, Yves Fradet, Thomas A. Griffin, Peter De Porre, Anil Londhe, Thian Kheoh, Eric J. Small, Howard I. Scher, Arturo Molina, and Charles J. Ryan, “Impact of Bone-targeted Therapies in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA-302,” European Urology, 2015. View at Publisher · View at Google Scholar
  • Francesca Khani, and Brian D. Robinson, “A “Chicken or Egg” Conundrum: Race, Molecular Subtype, and Tumor Location in Prostate Cancer,” European Urology, 2015. View at Publisher · View at Google Scholar
  • Roderick C.N. van den Bergh, Niels J. van Casteren, Thomas van den Broeck, Eve R. Fordyce, William K.M. Gietzmann, Fiona Stewart, Steven MacLennan, Saeed Dabestani, Joaquim Bellmunt, Michel Bolla, Erik Briers, Philip Cornford, Steven Joniau, Malcolm D. Mason, Vsevolod Matveev, Henk G. van der Poel, Theo H. van der Kwast, Olivier Rouvière, Thomas Wiegel, Thomas B. Lam, and Nicolas Mottet, “Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review,” European Urology, 2015. View at Publisher · View at Google Scholar
  • Stéphane Oudard, Pablo Maroto, Gaston Demonty, and Winald R. Gerritsen, “Charting Recent Progress and Challenges in Metastatic Castration-resistant Prostate Cancer: Is There an Optimal Treatment Sequence?,” European Urology Focus, 2015. View at Publisher · View at Google Scholar
  • Yingjie Cao, Xinzhong Huang, Yaping Fan, and Xiaolan Chen, “ Protective Effect of Triptolide against Glomerular Mesangial Cell Proliferation and Glomerular Fibrosis in Rats Involves the TGF- β 1/Smad Signaling Pathway ,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Yan Zhu, Chengshan Li, Aichen Su, Yuanye Wang, and Shengnian Zhou, “Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer's disease,” Experimental and Therapeutic Medicine, 2015. View at Publisher · View at Google Scholar
  • Jun Guo, Shu-Hong Wu, Wei-Guo Ren, Xin-Li Wang, and Ai-Qing Yang, “Anticancer activity of bicalutamide-loaded PLGA nanoparticles in prostate cancers,” Experimental And Therapeutic Medicine, vol. 10, no. 6, pp. 2305–2310, 2015. View at Publisher · View at Google Scholar
  • Yong Gao, Puxian Li, Zhenrui Liu, Xingtao Diao, and Chunyun Song, “Expression levels of vascular endothelial cell growth factor and microRNA-210 are increased in medulloblastoma and metastatic medulloblastoma,” Experimental And Therapeutic Medicine, vol. 10, no. 6, pp. 2138–2144, 2015. View at Publisher · View at Google Scholar
  • Kenneth C Valkenburg, and Kenneth J Pienta, “Drug discovery in prostate cancer mouse models,” Expert Opinion on Drug Discovery, pp. 1–14, 2015. View at Publisher · View at Google Scholar
  • Alexandru Dan Grigore, Eshel Ben-Jacob, and Mary C. Farach-Carson, “Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?,” Frontiers in Oncology, vol. 5, 2015. View at Publisher · View at Google Scholar
  • Kashyap Shatagopam, Hristos Z. Kaimakliotis, Liang Cheng, and Michael O. Koch, “Genitourinary small cell malignancies: prostate and bladder,” Future Oncology, vol. 11, no. 3, pp. 479–488, 2015. View at Publisher · View at Google Scholar
  • Andreas G Wibmer, Hebert Alberto Vargas, and Hedvig Hricak, “Role of MRI in the diagnosis and management of prostate cancer,” Future Oncology, 2015. View at Publisher · View at Google Scholar
  • Y. Zhao, J. Liang, J. G. Qi, N. Yang, G. Wu, Y. L. Lin, J. Y. Cao, Q. Wang, and Q. C. Wang, “Meta-analysis of the association between the HNF1B rs4430796 (A>G) polymorphism and risk of prostate cancer based on case-control studies,” Genetics And Molecular Research, vol. 14, no. 3, pp. 7426–7435, 2015. View at Publisher · View at Google Scholar
  • Atsushi Imai, Kazutoshi Matsunami, Satoshi Ichigo, and Hiroshi Takagi, “Minodronic acid suppresses gonadotropin-releasing hormone agonist-induced bone remodeling biomarkers: a retrospective pilot study,” Gynecological Endocrinology, pp. 1–3, 2015. View at Publisher · View at Google Scholar
  • Craig R. Ramsay, Temitope E. Adewuyi, Joanne Gray, Jenni Hislop, Mark D. F. Shirley, Shalmini Jayakody, Graeme MacLennan, Cynthia Fraser, Sara MacLennan, Miriam Brazzelli, James N'Dow, Robert Pickard, Clare Robertson, Kieran Rothnie, Stephen P. Rushton, Luke Vale, and Thomas B. Lam, “Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation,” Health Technology Assessment, vol. 19, no. 49, pp. 1–+, 2015. View at Publisher · View at Google Scholar
  • Michael J Hall, Karen J Ruth, David YT Chen, Laura M Gross, and Veda N Giri, “Interest in genomic SNP testing for prostate cancer risk: a pilot survey,” Hereditary Cancer in Clinical Practice, vol. 13, no. 1, 2015. View at Publisher · View at Google Scholar
  • David C. Qian, Jinyoung Byun, Younghun Han, Casey S. Greene, John K. Field, Rayjean J. Hung, Yonathan Brhane, John R. Mclaughlin, Gordon Fehringer, Maria Teresa Landi, Albert Rosenberger, Heike Bickeböller, Jyoti Malhotra, Angela Risch, Joachim Heinrich, David J. Hunter, Brian E. Henderson, Christopher A. Haiman, Fredrick R. Schumacher, Rosalind A. Eeles, Douglas F. Easton, Daniela Seminara, and Christopher I. Amos, “Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions,” Human Molecular Genetics, pp. ddv440, 2015. View at Publisher · View at Google Scholar
  • Stefan G. Schalk, Libertario Demi, Martijn Smeenge, David M. Mills, Kirk D. Wallace, Jean J. M. C. H. de la Rosette, Hessel Wijkstra, and Massimo Mischi, “4-D spatiotemporal analysis of ultrasound contrast agent dispersion for prostate cancer localization: a feasibility study,” IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 62, no. 5, pp. 839–851, 2015. View at Publisher · View at Google Scholar
  • Monika Izano, Esther K. Wei, Caroline Tai, Helen Swede, Steven Gregorich, Tamara B. Harris, Heidi Klepin, Suzanne Satterfield, Rachel Murphy, Anne B. Newman, Susan M. Rubin, and Dejana Braithwaite, “Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study,” International Journal of Cancer, 2015. View at Publisher · View at Google Scholar
  • S. Faithfull, A. Lemanska, P. Aslet, N. Bhatt, J. Coe, L. Drudge-Coates, M. Feneley, R. Glynn-Jones, M. Kirby, S. Langley, T. McNicholas, J. Newman, C. C. Smith, A. Sahai, E. Trueman, and H. Payne, “Integrative review on the non-invasive management of lower urinary tract symptoms in men following treatments for pelvic malignancies,” International Journal of Clinical Practice, 2015. View at Publisher · View at Google Scholar
  • M. Gierth, S. Denzinger, G. Liebig-Hörl, M. Burger, and A. Fürst, “Management of rectourinary fistula after urological interventions using biodesigned mesh: first experiences of an innovative technique,” International Journal of Colorectal Disease, 2015. View at Publisher · View at Google Scholar
  • Stefano Marventano, Paulina Kolacz, Sabrina Castellano, Fabio Galvano, Silvio Buscemi, Antonio Mistretta, and Giuseppe Grosso, “A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: does the ratio re,” International Journal Of Food Sciences And Nutrition, vol. 66, no. 6, pp. 611–622, 2015. View at Publisher · View at Google Scholar
  • Eva Tvrda, Ashok Agarwal, and Nawaf Alkuhaimi, “Male Reproductive Cancers and Infertility: A Mutual Relationship,” International Journal Of Molecular Sciences, vol. 16, no. 4, pp. 7230–7260, 2015. View at Publisher · View at Google Scholar
  • Stefania Clemente, Roberta Nigro, Caterina Oliviero, Chiara Marchioni, Marco Esposito, Francesca Romana Giglioli, Pietro Mancosu, Carmelo Marino, Serenella Russo, Michele Stasi, Lidia Strigari, Ivan Veronese, and Valeria Landoni, “Role of the Technical Aspects of Hypofractionated Radiation Therapy Treatment of Prostate Cancer: A Review,” International Journal of Radiation Oncology*Biology*Physics, vol. 91, no. 1, pp. 182–195, 2015. View at Publisher · View at Google Scholar
  • Jeffrey A. Kittel, Chandana A. Reddy, Kristin L. Smith, Kevin L. Stephans, Rahul D. Tendulkar, James Ulchaker, Kenneth Angermeier, Steven Campbell, Andrew Stephenson, Eric A. Klein, D. Allan Wilkinson, and Jay P. Ciezki, “Long-Term Efficacy and Toxicity of Low-Dose-Rate 125I Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer,” International Journal of Radiation Oncology*Biology*Physics, 2015. View at Publisher · View at Google Scholar
  • Victoria A. Harris, John Staffurth, Olivia Naismith, Alikhan Esmail, Sarah Gulliford, Vincent Khoo, Rebecca Lewis, John Littler, Helen McNair, Azmat Sadoyze, Christopher Scrase, Aslam Sohaib, Isabel Syndikus, Anjali Zarkar, Emma Hall, and David Dearnaley, “Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy,” International Journal of Radiation Oncology*Biology*Physics, vol. 92, no. 4, pp. 874–883, 2015. View at Publisher · View at Google Scholar
  • Yugo Sawada, Kazuya Omoto, Naoki Kohei, Kengo Sakaguchi, Masahiko Miura, and Kazunari Tanabe, “Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer,” International Journal of Urology, 2015. View at Publisher · View at Google Scholar